TMDX TransMedics Group Inc
Company Analysis
Latest News
🟢 TransMedics Group is trading 10.12% up as major indexes rise more than 1.7%
TransMedics Group is trading at $73.53, up +10.12%, amid broad market strength, with major indexes up more than 1.7%—the likeliest available explanation for...
TransMedics Group Inc Q3 2026 Earnings Preview: What Analysts Expect on November 05, 2026
Wall Street expects TransMedics Group to report Q3 2026 revenue of $178.05 million and EPS of $0.27, with the stock currently priced at $68.44 against an...
🔴 TransMedics Group is trading 4.22% down; no confirmed catalyst
TransMedics Group is trading at $66.79, down 4.22%, with no confirmed company-specific catalyst identified for October 28’s decline. - Available search...
🟢 TransMedics Group is trading 4.24% up in pre-market
TransMedics Group is trading 4.24% higher in pre-market at $73.62; no clear company-specific announcement or other confirmed catalyst for the October 27 move...
🟢 TransMedics Group rises 4.2% — Healthcare Stocks Surge on Sector Rotation Out of Tech
With Healthcare (XLV) up 2.1%, this looks like a sector-led move rather than a company-specific surprise. The healthcare sector is experiencing a significant...
🔴 TransMedics Group is trading 4.9% down
TransMedics Group is trading 4.9% down at $68.12, with no verified company announcement or same-day report establishing a specific cause. - The healthcare...
🔴 TransMedics Group is trading 4.82% down today with no confirmed catalyst
TransMedics Group is trading 4.82% down at $72.83, with no confirmed catalyst for the October 16 move. - No fresh company announcement explaining the move...
🟢 TransMedics Group is trading 4.3% up in pre-market amid a healthcare-sector rally
TransMedics Group is trading at $79.80, up 4.29%, in pre-market on October 16, 2026; healthcare-sector strength is the clearest available context for the...
🔴 TransMedics Group is trading 4.25% down today amid inflation and Treasury-yield concerns
TransMedics Group is trading at $75.77, down 4.25%, during the October 14 session amid broad market pressure as September inflation data renewed concerns about...
🟢 TransMedics Group is trading 4.44% up in pre-market with no confirmed company-specific catalyst
TransMedics Group is trading 4.44% up at $82.51 in pre-market; no fresh company-specific announcement explaining the move surfaced in the search. - Shares are...
🔴 TransMedics Group falls 4.2% — Healthcare Stocks Fall on Broad Market Geopolitical and Rate Fears
With Healthcare (XLV) down 1.5%, this looks like a sector-led move rather than a company-specific surprise. The healthcare sector declined, mirroring a wider...
TransMedics Gains on New 'Overweight' Rating from Barclays
Barclays initiated coverage on TransMedics Group (TMDX) on Wednesday, assigning the medical technology company an "overweight" rating. The bank set a price...
🟢 TransMedics Group is trading 4.1% up; no clear company-specific catalyst identified
TransMedics Group is trading 4.1% higher at $83.58, with no clear company-specific catalyst identified. - The gain comes as major indexes fall; healthcare is...
🟢 TransMedics Group is trading 4.02% up with no clear catalyst identified
TransMedics Group is trading at $83.00 (+4.02%); available coverage has not established a specific cause for the intraday gain. - The company’s latest listed...
🔴 TransMedics Group is trading 4.04% down; no clear company-specific catalyst
TransMedics Group is trading at $80.08, down 4.04%, with no clear company-specific catalyst identified in available news. - The latest spotlight article covers...
🔴 TransMedics Group is trading 4.4% down today as Treasury yields hit a 19-year high
TransMedics Group is trading 4.4% lower now at $83.15 as higher Treasury yields and broad risk-off trading pressure growth-oriented healthcare stocks. - The...
🟢 TransMedics Group is trading 40.21% up in after-hours trading — no confirmed catalyst identified
TransMedics Group is trading 40.21% up at $123.48 in after-hours trading, with no confirmed company-specific catalyst identified. - The company closed at...
TransMedics targets 20,000 U.S. transplants by 2030, launching next-gen tech
TransMedics set a target of 10,000 U.S. National OCS Program (NOP) cases by 2028. The company aims to reach 20,000 annual cases by 2030. Management expects to...
🟢 TransMedics Group is trading 4.08% up today as healthcare gains 1.28%
TransMedics Group is trading at $85.53, up +4.08%, as healthcare gains 1.28%, suggesting defensive sector rotation is supporting the move. • No new...
🔴 TransMedics Group is trading 4.3% down today — no clear company-specific catalyst identified
TransMedics Group is trading at $81.35, with a -4.34% change and no clear company-specific catalyst identified for the September 11, 2026 decline. - Fernando...